Original Research
Published on 18 Nov 2021
Drug Repositioning For Allosteric Modulation of VIP and PACAP Receptors
in Cellular Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2021.711906
- 6,224 views
- 11 citations
5 articles related to "P2y12 Antagonist"
Articles
Original Research
Published on 03 May 2018
Microglia P2Y13 Receptors Prevent Astrocyte Proliferation Mediated by P2Y1 Receptors
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2018.00418
- 6,821 views
- 40 citations
Clinical Trial
Published on 20 Jun 2018
Evaluation of Tolerability, Pharmacokinetics and Pharmacodynamics of Vicagrel, a Novel P2Y12 Antagonist, in Healthy Chinese Volunteers
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2018.00643
- 5,973 views
- 20 citations
Original Research
Published on 02 Nov 2022
Sex-related differences in the response of anti-platelet drug therapies targeting purinergic signaling pathways in sepsis
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2022.1015577
- 6,814 views
- 6 citations
Original Research
Published on 30 Aug 2021
Cardioprotecive Properties of Known Agents in Rat Ischemia-Reperfusion Model Under Clinically Relevant Conditions: Only the NAD Precursor Nicotinamide Riboside Reduces Infarct Size in Presence of Fentanyl, Midazolam and Cangrelor, but Not Propofol
in Cardiovascular Therapeutics
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2021.712478
- 5,902 views
- 14 citations